• Canon Upgraded to Buy by Zacks Investment Research

    23 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Canon from a hold rating to a buy rating in a report released on Tuesday, Zacks.com reports. The brokerage currently has $28.00 price target on the technology company's stock.
    According to Zacks, “Canon, Inc. is an industry leader in professional and consumer imaging equipment and information systems. Canon's extensive product line enables businesses and consumers worldwide to capture, store and distribute visual information. Canon products include full-color as well as black and white copiers; color laser printers; facsimile machines...
    Read more ...

     

  • Carriage Services Stock Rating Lowered by Zacks Investment Research

    Carriage Services Stock Rating Lowered by Zacks Investment Research

    23 days ago - By ETF Daily News

    Zacks Investment Research downgraded shares of Carriage Services from a buy rating to a hold rating in a research note issued to investors on Tuesday, Zacks.com reports.
    According to Zacks, “Carriage Services, Inc. is a leading provider of death care services and products in the United States. Carriage provides a complete range of services relating to funerals, burials and cremations, including the use of funeral homes and motor vehicles, the performance of cemetery interment services and the management and maintenance of cemetery grounds. They also sell related products and merchandise...
    Read more ...

     

  • Zacks Investment Research Upgrades Axcella Health to Buy

    Zacks Investment Research Upgrades Axcella Health to Buy

    23 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Axcella Health from a hold rating to a buy rating in a report published on Tuesday, Zacks.com reports. The brokerage currently has $2.50 price target on the stock.
    According to Zacks, “Axcella Health Inc. is a biotechnology company. It is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The company's principal candidate consists of AXA1665, AXA1125, AXA1957, AXA2678 and AXA4010 which are in clinical stage. Axcella Health Inc. is based in Cambridge, Massachusetts...
    Read more ...

     

  • Soleno Therapeutics Cut to Hold at Zacks Investment Research

    Soleno Therapeutics Cut to Hold at Zacks Investment Research

    23 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of Soleno Therapeutics from a buy rating to a hold rating in a research report report published on Tuesday, Zacks.com reports.
    According to Zacks, “Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada. “
    Soleno...
    Read more ...

     

  • Radius Global Infrastructure Upgraded by Zacks Investment Research to Buy

    Radius Global Infrastructure Upgraded by Zacks Investment Research to Buy

    23 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Radius Global Infrastructure from a hold rating to a buy rating in a research report report published on Tuesday, Zacks.com reports. They currently have $18.00 price target on the stock.
    According to Zacks, “RADIUS GLBL INF is a blank check company. It aims to acquire a business via a merger, capital stock exchange, asset acquisition, stock purchase and reorganization. RADIUS GLBL INF is based in New York. “
    RADI has been the subject of a number of other reports. Raymond James raised Radius Global Infrastructure from an outperform rating to a...
    Read more ...

     

  • IQIYI Coverage Initiated at Benchmark

    IQIYI Coverage Initiated at Benchmark

    23 days ago - By ETF Daily News

    Benchmark started coverage on shares of iQIYI in a research report sent to investors on Tuesday morning, The Fly reports. The brokerage issued a hold rating on the stock.
    IQ has been the subject of several other reports. UBS Group cut shares of iQIYI from a buy rating to a neutral rating and decreased their price objective for the company from $18.50 to $9.50 in a report on Tuesday, November 2nd. OTR Global reissued a positive rating on shares of iQIYI in a report on Tuesday, October 5th. Finally, Citigroup decreased their price objective on shares of iQIYI from $10.00 to $8.80 and set a...
    Read more ...

     

  • Frontline Lifted to Hold at Zacks Investment Research

    Frontline Lifted to Hold at Zacks Investment Research

    23 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Frontline from a sell rating to a hold rating in a research report report published on Tuesday, Zacks.com reports.
    According to Zacks, “FRONTLINE LTD's business strategy is primarily based upon the following principles: emphasising operational safety and quality maintenance for all of its vessels; complying with all current and proposed environmental regulations; outsourcing technical operations and crewing; achieving low operational costs of vessels; achieving high utilisation of its vessels; competitive financing arrangements; and develop...
    Read more ...

     

  • First Business Financial Services Downgraded to Hold at Zacks Investment Research

    First Business Financial Services Downgraded to Hold at Zacks Investment Research

    23 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of First Business Financial Services from a buy rating to a hold rating in a research note released on Tuesday morning, Zacks.com reports.
    According to Zacks, “First Business Financial Services is the parent of the First Business family of companies, managing shareholder relations and providing access to capital for our operating entities. It provides its subsidiaries with cost-effective corporate services including human resources, finance, information technology, and marketing. Its companies include First Business Bank, First Business Bank...
    Read more ...

     

  • Zacks Investment Research Lowers Guaranty Federal Bancshares to Hold

    Zacks Investment Research Lowers Guaranty Federal Bancshares to Hold

    23 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of Guaranty Federal Bancshares from a buy rating to a hold rating in a report issued on Tuesday, Zacks.com reports.
    According to Zacks, “Guaranty Federal Bancshares, Inc. has a subsidiary corporation offering full banking services. The principal subsidiary, Guaranty Bank, is headquartered in Springfield, Missouri, and has nine full-service branches in Greene and Christian Counties and a Loan Production Office in Webster County. Guaranty Bank is a member of the MoneyPass and TransFund ATM networks which provide its customers surcharge free access to...
    Read more ...

     

  • Entegris Upgraded by Zacks Investment Research to “Buy”

    Entegris Upgraded by Zacks Investment Research to “Buy”

    23 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Entegris from a hold rating to a buy rating in a research report report published on Tuesday, Zacks.com reports. Zacks Investment Research currently has $158.00 price target on the semiconductor company's stock.
    According to Zacks, “Entegris is a leading provider of materials management solutions to the microelectronics industry including, in particular, the semiconductor manufacturing and disk manufacturing markets. The company's materials management solutions for the semiconductor industry assure the integrity of materials as they are handled...
    Read more ...

     

  • Heidrick & Struggles International Stock Rating Lowered by Zacks Investment Research

    Heidrick & Struggles International Stock Rating Lowered by Zacks Investment Research

    23 days ago - By ETF Daily News

    Heidrick & Struggles International was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Monday, Zacks.com reports.
    According to Zacks, “Heidrick & Struggles International, Inc. serves the executive talent and leadership needs of the world's top organizations as the premier provider of leadership consulting, culture shaping and senior-level executive search services. Heidrick & Struggles International, Inc. is one of the leading global executive search firms. With years of experience in fulfilling their clients' leadership needs...
    Read more ...

     

  • Fury Gold Mines Stock Rating Upgraded by Zacks Investment Research

    Fury Gold Mines Stock Rating Upgraded by Zacks Investment Research

    23 days ago - By ETF Daily News

    Fury Gold Mines was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Monday, Zacks.com reports. The firm currently has a $0.75 target price on the stock. Zacks Investment Research ‘s price target would suggest a potential upside of 14.70% from the stock's current price.
    According to Zacks, “Fury Gold Mines Limited is an exploration and development company. It principally explores for gold. The company's prime project includes Eau Claire project and Committee Bay gold project. Fury Gold Mines Limited is based in Toronto, Canada...
    Read more ...

     

  • Bank of Marin Bancorp Upgraded to “Buy” at Zacks Investment Research

    Bank of Marin Bancorp Upgraded to “Buy” at Zacks Investment Research

    23 days ago - By ETF Daily News

    Bank of Marin Bancorp was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, Zacks.com reports. The brokerage currently has a $41.00 target price on the bank's stock. Zacks Investment Research ‘s price objective would indicate a potential upside of 10.24% from the company's previous close.
    According to Zacks, “Bank of Marin is a California State chartered bank. “
    NASDAQ:BMRC opened at $37.19 on Monday. Bank of Marin Bancorp has a fifty-two week low of $30.69 and a fifty-two week high of $42.19. The company has a...
    Read more ...

     

  • Bark & Co Stock Rating Upgraded by Zacks Investment Research

    Bark & Co Stock Rating Upgraded by Zacks Investment Research

    23 days ago - By ETF Daily News

    Bark & Co was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, Zacks.com reports. The brokerage presently has a $4.50 target price on the stock. Zacks Investment Research ‘s target price would suggest a potential upside of 10.29% from the stock's current price.
    According to Zacks, “ORIGINAL BARK is a dog-centric company. It devoted to making dogs happy with the products, services and content. ORIGINAL BARK, formerly known as Northern Star Acquisition Corp., is based in NEW YORK. “
    Separately, Citigroup lowered...
    Read more ...

     

  • Hope Bancorp Upgraded to Buy by Zacks Investment Research

    Hope Bancorp Upgraded to Buy by Zacks Investment Research

    23 days ago - By ETF Daily News

    Hope Bancorp was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. The brokerage presently has a $16.00 target price on the financial services provider's stock. Zacks Investment Research ‘s price objective suggests a potential upside of 9.14% from the stock's current price.
    According to Zacks, “Hope Bancorp Inc. operates as the bank holding company which provides commercial banking services primarily to small- to medium-sized businesses and individuals primarily in the United...
    Read more ...

     

  • Terns Pharmaceuticals Lowered to “Hold” at Zacks Investment Research

    Terns Pharmaceuticals Lowered to “Hold” at Zacks Investment Research

    24 days ago - By ETF Daily News

    Zacks Investment Research cut shares of Terns Pharmaceuticals from a buy rating to a hold rating in a research note released on Saturday morning, Zacks.com reports.
    According to Zacks, “Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY, Calif. “
    Separately, The Goldman Sachs Group initiated coverage on shares of Terns Pharmaceuticals in a...
    Read more ...

     

  • Carlsberg A/S Stock Rating Lowered by Zacks Investment Research

    Carlsberg A/S Stock Rating Lowered by Zacks Investment Research

    24 days ago - By ETF Daily News

    Carlsberg A/S was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports.
    According to Zacks, “Carlsberg A/S is a brewing company and has operations in Northern & Western Europe, Eastern Europe and Asia. Its beer portfolio includes more than 500 brands. The company offers its products primarily under the Carlsberg, Tuborg, Baltika, and Kronenbourg 1664 names and local brands such as Ringnes in Norway, Feldschlösschen in Switzerland, Lav in Serbia, and Wusu in western China. Carlsberg A/S is based in...
    Read more ...

     

  • Vor Biopharma Stock Rating Lowered by Zacks Investment Research

    Vor Biopharma Stock Rating Lowered by Zacks Investment Research

    24 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of Vor Biopharma from a buy rating to a hold rating in a report issued on Saturday, Zacks.com reports.
    According to Zacks, “Vor Biopharma Inc. is a cell therapy company pioneering engineered hematopoietic stem cell therapies combined with targeted therapies for the treatment of cancer. Vor Biopharma Inc. is based in CAMBRIDGE, Mass. “
    A number of other research analysts have also recently issued reports on the company. Oppenheimer began coverage on Vor Biopharma in a report on Wednesday, December 1st. They issued an outperform rating and a $30.00...
    Read more ...

     

  • AB Volvo Stock Rating Lowered by Zacks Investment Research

    AB Volvo  Stock Rating Lowered by Zacks Investment Research

    24 days ago - By ETF Daily News

    Zacks Investment Research downgraded shares of AB Volvo from a buy rating to a hold rating in a research note released on Saturday, Zacks.com reports.
    According to Zacks, “AB Volvo is the parent company of the Volvo Group. The Volvo Group is a manufacturer of trucks, buses, construction equipment, diesel engines, and marine and industrial engines. The Volvo Group also provides solutions for financing and service. Its segments include Trucks, Construction Equipment, Buses, Volvo Penta, Group functions & Other, and Financial Services. The Company's brand portfolio consists of Volvo, Volvo...
    Read more ...

     

  • Gerdau Rating Increased to Strong-Buy at Zacks Investment Research

    Gerdau Rating Increased to Strong-Buy at Zacks Investment Research

    24 days ago - By ETF Daily News

    Gerdau was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a report issued on Monday, Zacks.com reports. The brokerage currently has a $5.50 price target on the basic materials company's stock. Zacks Investment Research ‘s price objective points to a potential upside of 14.35% from the company's current price.
    According to Zacks, “GERDAU S.A. throughout its 101 years of activities, they are largest long steel producer in Latin America, and have made an important contribution in building the history of the Brazilian industry. Gerdau Group dedicates...
    Read more ...